Find an expert

Dr Moni holds a PhD in Artificial Intelligence & Data Science in 2014 from the University of Cambridge, UK followed by postdoctoral training at the University of New South Wales, University of Sydney Vice-chancellor fellowship, and Senior Data Scientist at the University of Oxford. Dr Moni then joined UQ in 2021. He also worked as an assistant professor and lecturer in two universities (PUST and JKKNIU) from 2007 to 2011. He is an Artificial Intelligence, Computer Vision & Machine learning, Digital Health Data Science, Health Informatics and Bioinformatics researcher developing interpretable and clinical applicable machine learning and deep learning models to increase the performance and transparency of AI-based automated decision-making systems.

His research interests include quantifying and extracting actionable knowledge from data to solve real-world problems and giving humans explainable AI models through feature visualisation and attribution methods. He has applied these techniques to various multi-disciplinary applications such as medical imaging including stroke MRI/fMRI imaging, real-time cancer imaging. He led and managed significant research programs in developing machine-learning, deep-learning and translational data science models, and software tools to aid the diagnosis and prediction of disease outcomes, particularly for hard-to-manage complex and chronic diseases. His research interest also includes developing Data Science, machine learning and deep learning algorithms, models and software tools utilising different types of data, especially medical images, neuroimaging (MRI, fMRI, Ultrasound, X-Ray), EEG, ECG, Bioinformatics, and secondary usage of routinely collected data.

• I am currently recruiting graduate students. Check out Available Projects for details. Open to both Domestic and International students.

Gloria is a Lecturer in Chemical Engineering and an Advance Queensland Industry Research Fellow at UQ’s School of Chemical Engineering. She applies multiscale simulation techniques, combining molecular simulations with macroscopic physics-based modelling, to address energy and environmental challenges. Working at the interface of applied mathematics and engineering, she develops predictive models to understand complex system behaviour and computational methods to enhance simulation tools across chemical engineering applications.

Her expertise spans membrane science, nanocomposites, transport phenomena, and chemical kinetics, with a focus on adsorption, diffusion, and permeation in nanocomposites, as well as reaction engineering of complex chemical systems. She integrates Bayesian statistics, physical modelling, computational chemistry, and experimental validation to optimize carbon capture technologies for climate change mitigation and advance the development of sustainable chemical processes.

Professor Michael Monteiro has established an international reputation in the field of 'living' radical polymerization to create complex polymer architectures. He is now building designer polymers for various biomedical applications, including vaccines, drug delivery and stem cells. He is dedicated to translating research into commercial outcomes, with 7 PCT and provisional patents since 2005 and start-up company DendriMed Pty Ltd. He was awarded an ARC QEII Fellowship in 2004 and an ARC Future Fellowship in 2009. He has attracted ARC and NHMRC grants; and Queensland State Government funding in excess of $7 million.

International links

Professor Monteiro has built a strong collaboration with Professor Virgil Percec from the University of Pennsylvania to develop and understand the new SET-LRP. He has developed a collaboration with Professor Rachel O'Reilly from the University of Warwick to develop nanoreactors that mimic enzyme activity. In collaboration with Professor Eugenia Kumacheva from the University of Toronto, they developed temperature responsive micron-sized particles from encapsulation of cells.

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy and Pharmaceutical Sciences at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Dr Shehzahdi (Sheb) Moonshi is a nanobiologist and translational immunology researcher at the University of Queensland’s Frazer Institute and Translational Research Institute (TRI). Her research focuses on developing antigen-specific immunotherapies (ASI) and nanoparticle-based precision medicines to treat autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.

At TRI (2025), she has translated this skillset to optimise antigen-specific liposomal nanotherapies for in vitro stability and evaluate their biodistribution and efficacy in vivo using preclinical models of autoimmune disease. She has also developed unique expertise in creating scalable, immune-targeted delivery platforms for clinical translation through close collaboration with a Clinical Drug Manufacturing Organisation for the scale-up and manufacture of ASITI-RA, a rheumatoid arthritis antigen-specific immunotherapy.

Her broader expertise spans:

• Nanomedicine formulation and characterisation

• Translational immunology and preclinical model development (humanised mice)

• Collaborative, consumer-partnered, and clinician-led translational research

Dr Moonshi’s goal is to advance precision immunotherapies that restore immune tolerance and transform outcomes for people with autoimmune and inflammatory diseases.

Emeritus Prof Moore’s research interests include: history of Australia, Queensland, Pacific Islands, New Guinea, Papua New Guinea, and Solomon Islands,.

Emeritus Prof Moore holds a BA and PhD from James Cook University. His teaching at UQ covered Australia, Queensland, and the Pacific Islands, colonial and race relations history, and the history of gender and sexuality. He was Head of the School of History, Philosophy, Religion and Classics from 2008 to 2013.

Emeritus Prof Moore held the McCaughey Chair in History. He has been a member of the Board of the Journal of Pacific History since 1998. In 1999 he headed the Queensland team for the National Archives Founding Documents Webpage. During 2000-01 he served on a Panel of Enquiry into the restructure of the University of PNG and authored a UNESCO report on higher distance education in UPNG. In 2005 he was awarded a Cross of Solomon Islands for his work on Solomon Islands history. He was President of the Australian Association for the Advancement of Pacific Studies from 2006 to 2010 and was elected a Fellow of the Australian Academic of the Humanities in 2011.

He has contunued to research and publish on Solomon Islands and Queensland.

Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, a unique resource located on the Queensland Children's Hospital precinct, facilitating local, national and international collaborative research across all childhood cancer types and supporting enrolment of children on clinical trials. A/Prof. Moore's clinical and research interests focus on childhood leukaemia, particularly acute myeloid leukaemia (AML), an aggressive form of leukaemia with a poor prognosis. He also holds a number of leadership and advisory roles, including Deputy Chair of the Australian & New Zealand Childrens Haematology / Oncology Group (ANZCHOG).

Paul Moore is a senior lecturer in the postgraduate Applied Linguistics program in The School of Languages and Cultures, specialising in Language and Technology and Sociocultural Theory. Paul’s main research interest involves the dynamic influence of learners, tasks and sociocultural context on task-based interaction, performance and development. Recent projects have included ecological CALL teacher training, sociocognitive interpretations of language test performance, language policy in higher education, and the intersection between language and intercultural communication.

Professor Moorhead works in late antique and early medieval history.

A graduate of the universities of New England and Liverpool, he is a Fellow of the Australian Academy of the Humanities and has walked the medieval pilgrim trail from Le Puy to Santiago.

Prof Alina Morawska is Director of the Parenting and Family Support Centre, The University of Queensland. She is passionate about creating a world where children develop the skills, competencies and confidence to adapt and thrive in an ever-changing world. Her research focuses on the central role of parents in influencing all aspects of children’s development, and parenting interventions as a way of understanding healthy development, a means for promoting positive family relationships, and a tool for the prevention and early intervention in lifelong health and wellbeing. She has published extensively in the field of parenting and family intervention and has received numerous grants to support her research. She has been recognised as Australia’s top scholar in family studies.

Professor Matthew Morell has had an extensive career over four decades characterised by his focus on conducting and leading high-quality agricultural research that delivers benefits to the agriculture and food sectors, and to consumers. In leadership, Professor Morell has a track record in developing effective teams and working with institutions and their stakeholders to deliver innovations for the future.

As Director of QAAFI, Professor Morell is highly motivated by the opportunity to lead research programs that provide research and knowledge based solutions to many of the major big challenges of our times, including enhancing both profitability and sustainability in agricultural production, providing improved nutrition, building resilience in the face of climate change, and reducing the environmental footprint of agriculture, all in ways that protect and build the livelihoods of farmers and rural communities. The mission of QAAFI in providing benefits to Queensland through working closely with producers, the food industry, the Department of Agriculture and Fisheries, and other research partners and stakeholders across the state, provides a highly fertile ground for conducting and delivering research that makes a significant difference to Queensland and its people. QAAFI has an important role serving as a focal point for Queensland in engaging nationally and internationally with global efforts to find solutions to global challenges in agriculture and food production.

Over the past seven years, Professor Morell led research in an international development context at the International Rice Research Institute (IRRI) based in the Philippines. As IRRI’s CEO for the past five years, he led the institute’s affairs across 17 countries, set strategic direction in close consultation with its Board of Trustees, staff and stakeholders. Prior to his appointment as CEO, Professor Morell was IRRI’s Deputy Director General (Research), driving research and outreach programs across various dimensions of rice science including climate change-ready rice, healthier varieties, environmentally sustainable farming systems, and capacity development. In his leadership at IRRI, Professor Morell instilled a strong focus on both understanding and meeting the needs of stakeholders and beneficiaries, he strengthened IRRIs regional presence, particularly through the establishment of the IRRI South Asia Research Centre, and drove modernisation of the Institute's research operations to be more effective and efficient.

Before joining IRRI, Professor Morell worked for 17 years at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), where he initiated, developed, and led a research program on future grains and plant oil production. Dr Morell has extensive experience in working closely with industry and in identifying, protecting, and managing intellectual property. His work at CSIRO resulted in the formation of two spin off companies which have commercialised novel grains delivering human health benefits. He holds a PhD in agricultural chemistry from the University of Sydney; conducted postdoctoral studies at the University of Michigan and the University of California, Davis; and was a research fellow at the Australian National University. He is an Academy Fellow of the International Association of Cereal Chemists and of the Academy of Technological Sciences and Engineering of Australia. (ATSE).

Prof Morgan was the Director of the Centre for Hypersonics since its inception in 1997 until October 2021. He lectures in mechanical and aerospace engineering within the School of Mechanical and Mining Engineering.

He has a strong research record in the development of hypervelocity impulsive facilities on which the UQ Centre for Hypersonics research program is based, including the ‘X’ series of super-orbital expansion tubes, and has extensive experience in hypersonic aero-thermo-dynamics and scramjet propulsion.

Richard Morgan has been developing superorbital ground based facilities for many years, and has collaborative research program with DSTG, NASA, ESA, Oxford University, Ecole Centrale (Paris) and AOARD in radiating flows, as well as continuing ARC support in this area since 1990, including two current ARC Discovery grants in partnership with European and American partners.

He was involved as a flight team member in the 2010 airborne observation of the Japanese ‘Hayabusa’ asteroid sample return mission, for which he was a co-recipient of the NASA Ames ‘honour’ award for 2010. He regularly gives invited talks in international meetings, and gave a plenary presentation to the AIAA Hypersonic Spaceplanes Conference in San Francisco in April 2011.

Professor Richard Morgan was awarded a 2012 UQ Excellence in Research Higher Degree Supervision award for encouraging student development through international student exchanges with overseas collaborators, whilst engendering internal cooperation within the study body.

Dr Michael Morgan is a mid-career academic with a robust foundation in basic sciences, who has built a distinguished path exploring the biological underpinnings of pain—particularly musculoskeletal pain and osteoarthritis. With influential lead author publications in PAIN, Osteoarthritis and Cartilage and Bone his work bridges molecular mechanisms and translational insights. Now pivoting toward clinical research, he is deepening his focus on another musculoskeletal condition, focusing on whiplash injury and the multidimensional nature of pain, driving cross-disciplinary studies that aim to connect lab findings with real-world patient outcomes.